PPARγ activation induces CD36 expression and stimulates foam cell like changes in rVSMCs
- 4 August 2006
- journal article
- Published by Elsevier in Prostaglandins & Other Lipid Mediators
- Vol. 80 (3-4), 165-174
- https://doi.org/10.1016/j.prostaglandins.2006.06.006
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pleiotropic Actions of PPARg Activators Thiazolidinediones in Cardiovascular DiseasesCurrent Pharmaceutical Design, 2004
- Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loadingProceedings of the National Academy of Sciences, 2003
- Differential Regulation of Lipogenesis and Leptin Production by Independent Signaling Pathways and Rosiglitazone During Human Adipocyte DifferentiationDiabetes, 2003
- Peroxisome proliferator‐activated receptor‐γ (PPAR‐γ) activation suppresses ischemic induction of Egr‐1 and its inflammatory gene targetsThe FASEB Journal, 2002
- Consequences of cellular cholesterol accumulation: basic concepts and physiological implicationsJournal of Clinical Investigation, 2002
- Enzymatically Degraded, Nonoxidized LDL Induces Human Vascular Smooth Muscle Cell Activation, Foam Cell Transformation, and ProliferationCirculation, 2000
- The Response-to-Retention Hypothesis of Early AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Development of the smooth muscle foam cell: uptake of macrophage lipid inclusions.Proceedings of the National Academy of Sciences, 1986
- The Pathogenesis of Atherosclerosis — An UpdateNew England Journal of Medicine, 1986
- Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1984